Natascha Helena Beyer

Suggest Changes

Writes About:

Learn More
Using the UNIarray® marker technology platform, cerebrospinal fluid immunoglobulin G reactivities of 15 controls and 17 RRMS patients against human recombinant proteins were investigated. Patient(More)